Yantai Zhigong Biopharmaceutical Technology Co., Ltd. is a high-tech enterprise co-founded by returned overseas scholars and experts in the biopharmaceutical industry, serving as the Yantai Transformation Base for Baiyuan Gene. The company is pioneering uncharted territory in the cancer‑related field, addressing critical gaps in clinical diagnostic needs for bladder cancer. Building on its research in bladder cancer genomics and the development of early‑diagnosis gene chips, the company is advancing the R&D and industrial-scale production of products for bladder cancer early warning, prognosis, pharmacotherapy, infection monitoring, and biochemical diagnostics.

Release Date:

2023-07-12

Yantai Zhigong Biopharmaceutical Technology Co., Ltd. is a high-tech enterprise co-founded by returned overseas scholars and experts in the biopharmaceutical industry, serving as the Yantai Transformation Base for Baiyuan Gene. The company is pioneering uncharted territory in the cancer‑related field, addressing critical gaps in clinical diagnostics for bladder cancer. Building on its research in bladder cancer genomics and the development of early‑diagnosis gene chips, the company is advancing the R&D and industrial-scale production of products for bladder cancer risk prediction, prognosis assessment, personalized medication guidance, infection monitoring, and biochemical diagnostics. Looking ahead, the company aims to become a “specialized, refined, distinctive, and innovative” enterprise in the field of molecular diagnostic instruments and associated reagents for reproductive‑tract tumors.

The Company’s Molecular Diagnostics Technology Innovation Center is a technology innovation hub established in Yantai by the Gansu Provincial Key Laboratory of Functional Genomics and Molecular Diagnostics and the Gansu Biochip Engineering Laboratory. Led by Professor Xu Jinzhang, a second‑level professor, and Professor Chen Yirong, a chief physician, the center leverages nucleic acid diagnostics, biochemical diagnostics, and immunoassay technologies to develop a range of rapid diagnostic methods across three key domains: medicine, environmental monitoring, and food safety. Its applications encompass the swift detection of infectious diseases, cancer, diabetes, and other conditions. The testing approaches incorporate compact, portable high‑throughput devices as well as flow‑based liquid‑phase chip technology, enabling deployment in diverse settings such as specialized testing facilities, hospitals, community health centers, and customs checkpoints.

The center is equipped with laboratories including an IVD instrument R&D lab, a molecular biology lab, a physiological and biochemical lab, a PCR lab, a separation and purification lab, a cell biology lab, a microbiology lab, and an immunology lab. It is furnished with specialized instruments and equipment, enabling it to meet the R&D needs for cutting-edge medical diagnostic instruments and associated diagnostic reagents. The center also provides services such as biomedical research support, technology development, technical consulting, technical exchange, and technology dissemination.

None